[1]
|
Knudson, A.G. (1985) Hereditary Cancer, Oncogenes, and Antioncogenes. Cancer Research, 45, 1437-1443.
|
[2]
|
Chung, G.T.Y., Huang, D.P., Lo, K.W., et al. (1992) Genetic Lesionin the Carc Inogenesis of Cervicalcancer. Anticaner Research, 12, 1485-1490.
|
[3]
|
Mitra, A.B., Murty, V.S., Li, R.G., et al. (1994) Chaganti, Allelotype Analysis of Cervical Carcinoma a. Cancer Re-search, 54, 4481-4487.
|
[4]
|
Rhyn, M.S. (1995) Telomere, Telomerase and Immortality. Journal of the National Cancer Institute, 87, 884-894.
https://doi.org/10.1093/jnci/87.12.884
|
[5]
|
Hoijt, S.E. and Shag, J.W. (1999) Role of Telomerase in Cellular Proliferation and Cancer. Journal of Cellular Physiology, 180, 10-18. https://doi.org/10.1002/(SICI)1097-4652(199907)180:1<10::AID-JCP2>3.0.CO;2-D
|
[6]
|
Tee, Y.T., Wang, P.H., Yang, S.F., et al. (2008) Lymph Node Metastases Not Human Telomerase Reverse Transcriptase or p53 Proteins, a the Strongest Prognostic Factor for Survival in Early Stage Cervica Cancer. Journal of Obstetrics and Gynaecology Research, 34, 1002-1009. https://doi.org/10.1111/j.1447-0756.2008.00861.x
|
[7]
|
Kloth, J.N., Oosting, J., van Wezel, T., et al. (2007) Combine Array Comparative Genomic Hybridization and Single Nucleotid Polymorphism Loss of Heterozygosity Analysis Reveals Complegenetic Alterations in Cervical Cancer. BMC Genomic, 20, 53-54.
|
[8]
|
Chen, J.L. and Greyer, C.W. (2004) Telomerase RNA Structure and Function Implication for Dys-Keration Congenital. Trends in Biochemical Sciences, 29, 183-190. https://doi.org/10.1016/j.tibs.2004.02.003
|
[9]
|
Blasco, M.A. and Greid, E.R. (1997) Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA. Cell, 5, 25234.
|
[10]
|
高宗侠, 凌斌. 人乳头瘤病毒、端粒酶、染色体异常与宫颈癌关系的研究进展[J]. 中国临床保健杂志, 2007, 3(10): 325-327.
|
[11]
|
Lee, D.K., Kim, B.C., Kim, I.Y., et al. (2002) The Human Papilloma Virus E7 Oncoprotein Inhibits Transforming Growth Factor-Be-Tasignaling by Blocking Binding of the Smad Complex to Its Target Sequence. The Journal of Biological Chemistry, 277, 38557-38564. https://doi.org/10.1074/jbc.M206786200
|
[12]
|
Favre Bonvin, A., Reynaud, C., Kretz Remy, C., et al. (2005) Human Papilloma Virus Type 18 E6 Protein Binds the Cellular PDZ Protein TIP-2/GIPC, Which Is Involved in Transforming Growth Factor Beta Sig-naling and Triggers Its Degradation by the Proteasome. Journal of Virology, 79, 4229-4237. https://doi.org/10.1128/JVI.79.7.4229-4237.2005
|
[13]
|
Mark, R.P., Trent, H., Roger, D.P., et al. (2006) Selection of Cervical Keratinocytes Containing Integrated HPV16 Associates with Episome Loss and an Endogenous Antiviral Response. PNAS, 103, 3822-3827.
https://doi.org/10.1073/pnas.0600078103
|
[14]
|
Snijder, P.J., Van, D.M., Walboomer, J.M., et al. (1998) Telomerase Activity Exclusively in Cervical Carcinomas and Subset of Cervical Intraepithelial Neoplasia Grade III Lesions: Strong Association with Elevated Messenger RNA Levels of Its Catalytic Subunit and High Risk Human Papillomavirus DNA. Cancer Research, 58, 3812-3818.
|
[15]
|
Aloysius, J., Klingelhutz, S.A., et al. (1996) Telomerase Activation by the E6 Gene Product of Human Papilloma-virus Type 16. Nature, 380, 791.
|
[16]
|
Hopman, A.H., Theelen, W., Hommelberg, P.P., et al. (2006) Genomic Integration of Onco-genic HPV and Gain of the Human Telomerase Gene TERC at 3q26 are Strongly Associated Events in the Progression of Uterine Cervical Dysplasia to Invasive Cancer. The Journal of Pathology, 210, 412-419. https://doi.org/10.1002/path.2070
|
[17]
|
Heselmeyer-Haddad, K., Sommerfeld, K., White, N.M., et al. (2005) Genomic Amplifi-cation of the Human Telomerase Gene (TERC) in Pap Smears Predicts the Development of Cervical Cancer. American Journal of Pathology, 166, 1229-1238. https://doi.org/10.1016/S0002-9440(10)62341-3
|
[18]
|
Hwang, T.S., Jeong, J.K., Park, M., et al. (2003) Detection and Typing of HPV Genotypes in Various Cervical Lesions by HPV Oligonucleotide Microarray. Gynecologic Oncology, 90, 51. https://doi.org/10.1016/S0090-8258(03)00201-4
|